{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:35:17Z","timestamp":1785429317557,"version":"3.56.0"},"reference-count":49,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Medical University of Bia\u0142ystok","doi-asserted-by":"publisher","award":["B.SUB.25.334"],"award-info":[{"award-number":["B.SUB.25.334"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]},{"award":["B.SUB.25.334"],"award-info":[{"award-number":["B.SUB.25.334"]}],"id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Peripherally restricted (\u2018second-generation\u2019) cannabinoid CB1 receptor (CB1R) antagonists have been suggested to have therapeutic potential in numerous diseases. However, their effects on the cardiovascular system require further research. The peripheral CB1R antagonist AM6545 failed to modify the decrease in blood pressure (BP) elicited by inhibition of anandamide degradation in spontaneously hypertensive rats. The aims of the present study were to examine the effect of AM6545 on BP and its interaction with endocannabinoid-evoked effects in deoxycorticosterone acetate (DOCA)-salt rats. For this purpose, we applied methanandamide (MethAEA), a stable analogue of anandamide, and URB597, an inhibitor of its degradation, in urethane-anesthetized animals. AM6545 did not affect BP by itself. MethAEA elicited a biphasic effect (a rise in BP, followed by its fall); both phases were antagonized by AM6545. URB597 induced a monophasic hypotensive effect, which was abolished by AM6545 in DOCA-salt rats but further enhanced in control animals. AM6545 also unmasked an additional increase in BP after URB597 in both groups of rats. In conclusion, AM6545 modifies the cardiovascular effects of endocannabinoids in hypertension in a model-dependent manner. The cardiovascular effects of CB1R antagonists should be carefully evaluated when assessing their potential therapeutic significance, as they may unmask an increase in BP.<\/jats:p>","DOI":"10.3390\/ijms27104449","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:40:31Z","timestamp":1779115231000},"page":"4449","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Short Communication: The Peripheral Cannabinoid CB1 Receptor Antagonist AM6545 Modifies Cardiovascular Effects of Endocannabinoids in DOCA-Salt Rats"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1346-2226","authenticated-orcid":false,"given":"Patryk","family":"Remiszewski","sequence":"first","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Schlicker","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8798-991X","authenticated-orcid":false,"given":"Emilia","family":"Grz\u0119da","sequence":"additional","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland"},{"name":"Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, 60-637 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2622-9391","authenticated-orcid":false,"given":"Jolanta","family":"Weresa","sequence":"additional","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5823-0269","authenticated-orcid":false,"given":"Marek","family":"Toczek","sequence":"additional","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Malinowska","sequence":"additional","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"107477","DOI":"10.1016\/j.pharmthera.2020.107477","article-title":"The therapeutic potential of second and third generation CB1R antagonists","volume":"208","author":"Cinar","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Dao, M., and Fran\u00e7ois, H. (2021). Cannabinoid receptor 1 inhibition in chronic kidney disease: A new therapeutic toolbox. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.720734"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan, S.E., Yates, A.S., and Porter, R.K. (2021). The peripheral cannabinoid receptor type 1 (CB1) as a molecular target for modulating body weight in man. Molecules, 26.","DOI":"10.3390\/molecules26206178"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","article-title":"Goods and bads of the endocannabinoid system as a therapeutic target: Lessons learned after 30 years","volume":"75","author":"Maccarrone","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41569-025-01121-6","article-title":"The relationship between cannabis and cardiovascular disease: Clearing the haze","volume":"22","author":"Chandy","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e187967","DOI":"10.1172\/jci.insight.187967","article-title":"Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis","volume":"10","author":"Basu","year":"2025","journal-title":"JCI Insight"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1111\/bph.70118","article-title":"Blockade of cannabinoid CB1 receptors potentiates the anti-fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy","volume":"182","author":"Pointeau","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e21232","DOI":"10.1096\/fj.202001960R","article-title":"Peripheral CB1R as a modulator of metabolic inflammation","volume":"35","author":"Han","year":"2021","journal-title":"FASEB J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-8587(25)00216-5","article-title":"Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: A double-blind, randomised, placebo-controlled, phase 2a trial","volume":"13","author":"Knop","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/bph.14168","article-title":"Cannabinoids in arterial, pulmonary and portal hypertension\u2014Mechanisms of action and potential therapeutic significance","volume":"176","author":"Malinowska","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","article-title":"Cardiovascular effects of marijuana and synthetic cannabinoids: The good, the bad, and the ugly","volume":"15","author":"Pacher","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_12","first-page":"343","article-title":"Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: Role of the paraventricular nucleus","volume":"66","author":"Schlicker","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/1440-1681.13297","article-title":"Stimulation of brain cannabinoid CB1 receptors can ameliorate hypertension in spontaneously hypertensive rats","volume":"47","author":"Shimizu","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e12108","DOI":"10.14814\/phy2.12108","article-title":"Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats","volume":"2","author":"Schaich","year":"2014","journal-title":"Physiol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","article-title":"Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension","volume":"110","author":"Pacher","year":"2004","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.chembiol.2010.08.013","article-title":"Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects","volume":"17","author":"Godlewski","year":"2010","journal-title":"Chem. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjp.0707410","article-title":"Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats","volume":"152","author":"Wheal","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.HYP.29.5.1204","article-title":"Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats","volume":"29","author":"Lake","year":"1997","journal-title":"Hypertension"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Eid, B.G., Neamatallah, T., Hanafy, A., El-Bassossy, H.M., Binmahfouz, L., Aldawsari, H.M., Hasan, A., El-Aziz, G.A., Vemuri, K., and Makriyannis, A. (2021). Interference with TGF\u03b21-mediated inflammation and fibrosis underlies reno-protective effects of the CB1 receptor neutral antagonists AM6545 and AM4113 in a rat model of metabolic syndrome. Molecules, 26, Correction in Molecules 2024, 29, 902. https:\/\/doi.org\/10.3390\/molecules29040902.","DOI":"10.3390\/molecules29040902"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11906-017-0731-4","article-title":"DOCA-salt hypertension: An update","volume":"19","author":"Basting","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_21","first-page":"e3708","article-title":"Development of the deoxycorticosterone acetate (DOCA)-salt hypertensive rat model","volume":"10","author":"Nahey","year":"2020","journal-title":"Bio Protoc."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Toczek, M., Schlicker, E., Remiszewski, P., and Malinowska, B. (2024). Function of presynaptic inhibitory cannabinoid CB1 receptors in spontaneously hypertensive rats and its modification by enhanced endocannabinoid tone. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020858"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2015.03.022","article-title":"Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats","volume":"138","author":"Toczek","year":"2015","journal-title":"Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/bph.13830","article-title":"Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats","volume":"174","author":"Weresa","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100070","DOI":"10.1016\/j.pharmr.2025.100070","article-title":"The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets","volume":"77","author":"Iannotti","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF01942510","article-title":"Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: Cardiovascular system","volume":"42","author":"Maggi","year":"1986","journal-title":"Experientia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0706195","article-title":"Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats","volume":"145","author":"Kwolek","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1152\/ajplegacy.1975.228.1.217","article-title":"Enhancement of hypothalamic pressor responses in spontaneously hypertensive rats","volume":"228","author":"Bunag","year":"1975","journal-title":"Am. J. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1113\/expphysiol.2008.046334","article-title":"Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats","volume":"95","author":"Yemane","year":"2010","journal-title":"Exp. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1476-5381.2009.00579.x","article-title":"A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats","volume":"160","author":"Zakrzeska","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.advms.2020.12.003","article-title":"Central nervous system, peripheral and hemodynamic effects of nanoformulated anandamide in hypertension","volume":"66","author":"Mazzei","year":"2021","journal-title":"Adv. Med. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.lfs.2016.03.014","article-title":"Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats","volume":"151","author":"Kloza","year":"2016","journal-title":"Life Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1021\/acs.jmedchem.0c00926","article-title":"Therapeutic exploitation of GPR18: Beyond the cannabinoids?","volume":"63","author":"Morales","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bjp.0707141","article-title":"Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol","volume":"150","author":"Ho","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12079-021-00622-6","article-title":"Endocannabinoid signaling pathways: Beyond CB1R and CB2R","volume":"15","author":"Biringer","year":"2021","journal-title":"J. Cell Commun. Signal."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00210-010-0497-6","article-title":"Involvement of central \u03b22-adrenergic, NMDA and thromboxane A2 receptors in the pressor effect of anandamide in rats","volume":"381","author":"Malinowska","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41386-022-01436-9","article-title":"Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism","volume":"48","author":"Ortega","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1111\/bph.70015","article-title":"Sub-chronic administration of AM6545 enhances cognitive performance and induces hippocampal synaptic plasticity changes in naive mice","volume":"182","author":"Maldonado","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.cmet.2019.04.012","article-title":"Targeting peripheral CB1 receptors reduces ethanol intake via a gut-brain axis","volume":"29","author":"Godlewski","year":"2019","journal-title":"Cell Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41380-025-03266-9","article-title":"CB1 receptors on a subset of vagal afferent neurons modulate voluntary ethanol intake in mice","volume":"31","author":"Herrerias","year":"2026","journal-title":"Mol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance","volume":"16","author":"Tam","year":"2012","journal-title":"Cell Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e0813232024","DOI":"10.1523\/JNEUROSCI.0813-23.2024","article-title":"Cholinergic neurotransmission controls orexigenic endocannabinoid signaling in the gut in diet-induced obesity","volume":"44","author":"Wood","year":"2024","journal-title":"J. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/jphp.12854","article-title":"Endocannabinoids modulate Gq\/11 protein-coupled receptor agonist-induced vasoconstriction via a negative feedback mechanism","volume":"70","author":"Kloza","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2013.01.002","article-title":"Modulation by 17\u03b2-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: A role for TRPV1 but not fatty acid amide hydrolase","volume":"701","author":"Ho","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s10194-025-02085-1","article-title":"Functional crosstalk between the vanilloid and endocannabinoid systems in modulating vascular tone: Implications for (neuro)vascular disorder therapy","volume":"26","author":"Danser","year":"2025","journal-title":"J. Headache Pain"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.HYP.35.2.679","article-title":"Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice","volume":"35","author":"Wagner","year":"2000","journal-title":"Hypertension"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e48609","DOI":"10.1097\/MD.0000000000048609","article-title":"Neuropeptides and endocannabinoid system as regulators of blood pressure in adolescents with primary hypertension","volume":"105","author":"Martyniak","year":"2026","journal-title":"Medicine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4449\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:29:46Z","timestamp":1779424186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104449"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104449","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]}}}